Eliquis

Experimental drug prevents blood clots from forming in legs and lungs

The experimental drug Eliquis prevented blood clots in the legs and lungs and kept them from recurring, according to a new study. Patients who took the medicine were 81% less likely to have symptoms of a clot or die than those who received a placebo, according to findings published in the New England Journal of Medicine.